organization · Reporting owner
Nukkleus Defense Technologies, Inc.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SC II Acquisition Corp.KCHV · Entity 6117 | 10% owner | November 28, 2025 | December 01, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SC II Acquisition Corp.
Report date November 28, 2025 · Filed December 01, 2025
Jointly reported with SC Capital II Sponsor LLC, T3 Defense Inc., Shalom Menachem
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A ordinary sharesSEC Table I · non-derivative | Direct | 255,000 |
Reported balance
After 2025-11-28 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-11-28 · Purchase · Acquired 255,000 · Balance 255,000 F1: Reflects the 255,000Class A ordinary shares of SC II Acquisition Corp. (the "Issuer") that are included in the 255,000 private placement units of the Issuer purchased by SC Capital II Sponsor LLC ("Sponsor"). Each private placement unit was purchased for $10 per unit and consists of one Class A ordinary share and one right to receive one-fifth (1/5) of one Class A ordinary share upon consummation of the Issuer's initial business combination. F2: The Sponsor is the record holder of the shares reported herein. The sole managing member of the Sponsor is Nukkleus Defense Technologies, Inc., a Nevada corporation (the "Managing Member"), which is a subsidiary of Nukkleus, Inc., a Delaware corporation ("Nukkleus"). Mr. Menachem Shalom is the CEO and a director of each of the Issuer, the Managing Member and Nukkleus. Mr. Shalom serves as the CEO and sole director of the Managing Member at the discretion of the Board of Directors of Nukkleus. Mr. Shalom, solely in his capacity as CEO and sole director of the Managing Member, has voting and dispositive control over the Class A ordinary shares and Class B ordinary shares held by the Sponsor and reported hereunder. Mr. Shalom disclaims beneficial ownership to these securities other than to the extent that he has a pecuniary interest therein. |
| Right to receive one-fifth of one Class A ordinary shareSEC Table II · derivative / convertible security | Direct | 7,443,857 |
Reported balance
After 2025-11-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-11-28 · Purchase · Acquired 255,000 · Balance 7,443,857 F3: Represents the 51,000 Class A ordinary shares, which may be acquired by Sponsor upon the conversion of 255,000 rights (included in the Sponsor's private placement units) upon consummation of the registrant's initial business combination. As described in the Registration Statement under the heading "Description of Securities-Share Rights," each right will automatically convert into one-fifth (1/5) of one Class A ordinary share upon consummation of the Issuer's initial business combination, subject to certain adjustments described therein. No fractional Class A ordinary shares will be issued upon conversion of such rights. F4: Represents (i) the 51,000 Class A ordinary shares referred to in footnotes 1 and 3 and (ii) 7,392,857 Class B ordinary shares held by the Sponsor acquired pursuant to a subscription agreement by and between the Issuer and the Sponsor. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the 255,000Class A ordinary shares of SC II Acquisition Corp. (the "Issuer") that are included in the 255,000 private placement units of the Issuer purchased by SC Capital II Sponsor LLC ("Sponsor"). Each private placement unit was purchased for $10 per unit and consists of one Class A ordinary share and one right to receive one-fifth (1/5) of one Class A ordinary share upon consummation of the Issuer's initial business combination.
F2: The Sponsor is the record holder of the shares reported herein. The sole managing member of the Sponsor is Nukkleus Defense Technologies, Inc., a Nevada corporation (the "Managing Member"), which is a subsidiary of Nukkleus, Inc., a Delaware corporation ("Nukkleus"). Mr. Menachem Shalom is the CEO and a director of each of the Issuer, the Managing Member and Nukkleus. Mr. Shalom serves as the CEO and sole director of the Managing Member at the discretion of the Board of Directors of Nukkleus. Mr. Shalom, solely in his capacity as CEO and sole director of the Managing Member, has voting and dispositive control over the Class A ordinary shares and Class B ordinary shares held by the Sponsor and reported hereunder. Mr. Shalom disclaims beneficial ownership to these securities other than to the extent that he has a pecuniary interest therein.
F3: Represents the 51,000 Class A ordinary shares, which may be acquired by Sponsor upon the conversion of 255,000 rights (included in the Sponsor's private placement units) upon consummation of the registrant's initial business combination. As described in the Registration Statement under the heading "Description of Securities-Share Rights," each right will automatically convert into one-fifth (1/5) of one Class A ordinary share upon consummation of the Issuer's initial business combination, subject to certain adjustments described therein. No fractional Class A ordinary shares will be issued upon conversion of such rights.
F4: Represents (i) the 51,000 Class A ordinary shares referred to in footnotes 1 and 3 and (ii) 7,392,857 Class B ordinary shares held by the Sponsor acquired pursuant to a subscription agreement by and between the Issuer and the Sponsor.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 28, 2025 Filed Dec 1, 2025 22:20 UTC | SC II Acquisition Corp. KCHV · Entity 6117 | PurchaseRight to receive one-fifth of one Class A ordinary share · Derivative | 255,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-25-116777 · ownership.xml · derivative · entry 2 SC Capital II Sponsor LLC · CIK 0002076738 · 10% owner Nukkleus Defense Technologies, Inc. · CIK 0002095058 · 10% owner Nukkleus Inc. · CIK 0001787518 · 10% owner Shalom Menachem · CIK 0002030245 · Director · CEO Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,443,857 Underlying: Class A Ordinary Shares · 51,000 shares Expires not disclosed F3 · derivative.exercise_price: Represents the 51,000 Class A ordinary shares, which may be acquired by Sponsor upon the conversion of 255,000 rights (included in the Sponsor's private placement units) upon consummation of the registrant's initial business combination. As described in the Registration Statement under the heading "Description of Securities-Share Rights," each right will automatically convert into one-fifth (1/5) of one Class A ordinary share upon consummation of the Issuer's initial business combination, subject to certain adjustments described therein. No fractional Class A ordinary shares will be issued upon conversion of such rights. F3 · shares: Represents the 51,000 Class A ordinary shares, which may be acquired by Sponsor upon the conversion of 255,000 rights (included in the Sponsor's private placement units) upon consummation of the registrant's initial business combination. As described in the Registration Statement under the heading "Description of Securities-Share Rights," each right will automatically convert into one-fifth (1/5) of one Class A ordinary share upon consummation of the Issuer's initial business combination, subject to certain adjustments described therein. No fractional Class A ordinary shares will be issued upon conversion of such rights. F3 · price: Represents the 51,000 Class A ordinary shares, which may be acquired by Sponsor upon the conversion of 255,000 rights (included in the Sponsor's private placement units) upon consummation of the registrant's initial business combination. As described in the Registration Statement under the heading "Description of Securities-Share Rights," each right will automatically convert into one-fifth (1/5) of one Class A ordinary share upon consummation of the Issuer's initial business combination, subject to certain adjustments described therein. No fractional Class A ordinary shares will be issued upon conversion of such rights. F3 · derivative.exercise_date: Represents the 51,000 Class A ordinary shares, which may be acquired by Sponsor upon the conversion of 255,000 rights (included in the Sponsor's private placement units) upon consummation of the registrant's initial business combination. As described in the Registration Statement under the heading "Description of Securities-Share Rights," each right will automatically convert into one-fifth (1/5) of one Class A ordinary share upon consummation of the Issuer's initial business combination, subject to certain adjustments described therein. No fractional Class A ordinary shares will be issued upon conversion of such rights. F3 · derivative.expiration_date: Represents the 51,000 Class A ordinary shares, which may be acquired by Sponsor upon the conversion of 255,000 rights (included in the Sponsor's private placement units) upon consummation of the registrant's initial business combination. As described in the Registration Statement under the heading "Description of Securities-Share Rights," each right will automatically convert into one-fifth (1/5) of one Class A ordinary share upon consummation of the Issuer's initial business combination, subject to certain adjustments described therein. No fractional Class A ordinary shares will be issued upon conversion of such rights. F3 · derivative.underlying_shares: Represents the 51,000 Class A ordinary shares, which may be acquired by Sponsor upon the conversion of 255,000 rights (included in the Sponsor's private placement units) upon consummation of the registrant's initial business combination. As described in the Registration Statement under the heading "Description of Securities-Share Rights," each right will automatically convert into one-fifth (1/5) of one Class A ordinary share upon consummation of the Issuer's initial business combination, subject to certain adjustments described therein. No fractional Class A ordinary shares will be issued upon conversion of such rights. F4 · balance_after: Represents (i) the 51,000 Class A ordinary shares referred to in footnotes 1 and 3 and (ii) 7,392,857 Class B ordinary shares held by the Sponsor acquired pursuant to a subscription agreement by and between the Issuer and the Sponsor. F3 · ownership.direct: Represents the 51,000 Class A ordinary shares, which may be acquired by Sponsor upon the conversion of 255,000 rights (included in the Sponsor's private placement units) upon consummation of the registrant's initial business combination. As described in the Registration Statement under the heading "Description of Securities-Share Rights," each right will automatically convert into one-fifth (1/5) of one Class A ordinary share upon consummation of the Issuer's initial business combination, subject to certain adjustments described therein. No fractional Class A ordinary shares will be issued upon conversion of such rights. Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 22:20 UTC | SC II Acquisition Corp. KCHV · Entity 6117 | PurchaseClass A ordinary shares | 255,000 | $10.00 | $2,550,000.00 |
DisclosureSEC source: 0001213900-25-116777 · ownership.xml · nonDerivative · entry 1 SC Capital II Sponsor LLC · CIK 0002076738 · 10% owner Nukkleus Defense Technologies, Inc. · CIK 0002095058 · 10% owner Nukkleus Inc. · CIK 0001787518 · 10% owner Shalom Menachem · CIK 0002030245 · Director · CEO Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,000 F1 · shares: Reflects the 255,000Class A ordinary shares of SC II Acquisition Corp. (the "Issuer") that are included in the 255,000 private placement units of the Issuer purchased by SC Capital II Sponsor LLC ("Sponsor"). Each private placement unit was purchased for $10 per unit and consists of one Class A ordinary share and one right to receive one-fifth (1/5) of one Class A ordinary share upon consummation of the Issuer's initial business combination. F2 · ownership.direct: The Sponsor is the record holder of the shares reported herein. The sole managing member of the Sponsor is Nukkleus Defense Technologies, Inc., a Nevada corporation (the "Managing Member"), which is a subsidiary of Nukkleus, Inc., a Delaware corporation ("Nukkleus"). Mr. Menachem Shalom is the CEO and a director of each of the Issuer, the Managing Member and Nukkleus. Mr. Shalom serves as the CEO and sole director of the Managing Member at the discretion of the Board of Directors of Nukkleus. Mr. Shalom, solely in his capacity as CEO and sole director of the Managing Member, has voting and dispositive control over the Class A ordinary shares and Class B ordinary shares held by the Sponsor and reported hereunder. Mr. Shalom disclaims beneficial ownership to these securities other than to the extent that he has a pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.